Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

SHA:603392 Revenue

Beijing Wantai Biological Pharmacy Enterprise had revenue of 525.12M CNY in the quarter ending June 30, 2026, with 18.55% growth. This brings the company's total for the last twelve months to 2.02B, up 17.47% year-over-year. In the year 2025, Beijing Wantai Biological Pharmacy Enterprise had annual revenue of 1.82B, down -18.99%. That makes Beijing Wantai Biological Pharmacy Enterprise the 14,461st largest company in the world by revenue and 2,579th in China.

• Revenue (ttm): 2.02B
• Revenue Growth: +17.47%
• P/S Ratio: 15.61
• Revenue / Employee: 491.71K
• Employees: 4,116
• Market Cap: 31.24B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Diagnostic Division 1.63B 78.1%
• Vaccine Division 457.05M 21.9%

By Geography

Chart

• China 1.35B 76.7%
• Overseas 412.11M 23.3%

Fiscal year ended Dec 31, 2025 See the full SHA:603392 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.82B	-426.44M	-18.99%
Dec 31, 2024	2.25B	-3.27B	-59.25%
Dec 31, 2023	5.51B	-5.67B	-50.73%
Dec 31, 2022	11.19B	5.43B	94.51%
Dec 31, 2021	5.75B	3.40B	144.25%

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error